Brian C. Healy, Ph.D

Instructor

50 Staniford St
Suite 560
Boston, MA 02114

E: bchealy@partners.org

Education: Bachelor of Science (Providence, RI)
Master of Arts (Boston, MA)
Doctor of Philosophy (Boston, MA) 2000 Sc.B Chemical Engineering,
Brown University, Providence, RI
2006 MA Biostatistics, Harvard University, Boston, MA
2007 PhD Biostatistics, Harvard University, Boston, MA

Postdoctoral Training: 2007-2008 Center of Neurological Diseases,
Harvard University, Boston, MA

Major research interests: Statistical methods development and
application for modeling of multiple
sclerosis. My present focus is the development of prediction models for
progression on the EDSS using variable selection techniques.

Publications:
Abdel-Wahab OI, Healy B, Dzik WH. Effect of fresh-frozen plasma transfusion on
prothrombin time and bleeding in patients with mild coagulation abnormalities.
Transfusion. 2006;46:1279-1285.

Healy B, DeGruttola V. Hidden Markov models for settings with
interval-censored
transition times and uncertain time origin: application to HIV genetic
analyses.
Biostatistics. 2007;8(2):438-52.

Rodriguez JR, Madanat MG, Healy BC, Thayer SP, Warshaw AL, Castillo CF.
Distal
pancreatectomy with splenic preservation revisited. Surgery.
2007;141(5):619-25.

Healy B, De Gruttola V, Pagano M. Combining Cross-Sectional and
Prospective Data
Methods to Improve Transition Parameter Estimation for Characterizing the
Accumulation of HIV-1 Drug Resistance Mutations. Biometrics
2007;63(3):742-750.

Healy BC, DeGruttola VG, and Hu C. Accommodating Uncertainty in a Tree Set for
Function Estimation. Statistical Applications in Genetics and Molecular
Biology
2008;7(1):5.

Viglietta V, Bourcier K, Buckle GJ, Healy BC, Weiner HL, Hafler DA, Egorova S,
Guttmann CRG, Rusche JR, Khoury SJ. CTLA4Ig treatment in patients with
multiple
sclerosis: an open-label, phase I clinical trial. Neurology, In Press

Liptak Z* and Berger AM*, Sampat MP, Charil A, Felsovalyi O, Healy BC, Khoury
SJ, Weiner HL, Bakshi R, Guttmann CRG. Medulla Oblongata Volume: A
Biomarker of
Spinal Cord Damage and Disability in Multiple Sclerosis. American Journal of
Neuroradiology, In Press.

Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA,
Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ,
Guttmann CRG, Weiner HL. Magnetic Resonance Disease Severity Scale (MRDSS)
predicts clinical progression in multiple sclerosis. Archives of Neurology, In
Press.